These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 30180269)

  • 1. Application of immortalized human erythroid progenitor cell line in serologic tests to detect red blood cell alloantibodies.
    Kikuchi G; Kurita R; Ogasawara K; Isa K; Tsuneyama H; Nakamura Y; Yabe R; Shiba M; Tadokoro K; Nagai T; Satake M
    Transfusion; 2018 Nov; 58(11):2675-2682. PubMed ID: 30180269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of immortalized bone marrow erythroid progenitor adult (imBMEP-A)-The first inducible immortalized red blood cell progenitor cell line derived from bone marrow CD71-positive cells.
    Kronstein-Wiedemann R; Thiel J; Sürün D; Teichert M; Künzel SR; Zimmermann S; Wagenführ L; Buchholz F; Tonn T
    Cytotherapy; 2024 Nov; 26(11):1362-1373. PubMed ID: 39001769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.
    Kurita R; Suda N; Sudo K; Miharada K; Hiroyama T; Miyoshi H; Tani K; Nakamura Y
    PLoS One; 2013; 8(3):e59890. PubMed ID: 23533656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of an erythroid progenitor cell line capable of enucleation achieved with an inducible c-Myc vector.
    Mayers S; Moço PD; Maqbool T; Silva PN; Kilkenny DM; Audet J
    BMC Biotechnol; 2019 Apr; 19(1):21. PubMed ID: 30987611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irradiation is not sufficient to eradicate residual immortalized erythroid cells in in vitro-generated red blood cell products.
    Kim S; Jo KW; Park JM; Shin A; Kurita R; Nakamura Y; Kweon S; Baek EJ
    Transfusion; 2023 Jun; 63(6):1122-1128. PubMed ID: 37154531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody.
    Kimoto T; Horibata K; Chikura S; Hashimoto K; Itoh S; Sanada H; Muto S; Uno Y; Yamada M; Honma M
    Mutat Res; 2013 Aug; 755(2):126-34. PubMed ID: 23792374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell production from immortalized progenitor cell line.
    Nakamura Y; Hiroyama T; Miharada K; Kurita R
    Int J Hematol; 2011 Jan; 93(1):5-9. PubMed ID: 21184289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
    Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
    N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growing and Genetically Manipulating Human Umbilical Cord Blood-Derived Erythroid Progenitor (HUDEP) Cell Lines.
    Vinjamur DS; Bauer DE
    Methods Mol Biol; 2018; 1698():275-284. PubMed ID: 29076097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Rare" reagent red cells: rare no longer?
    Chou ST
    Transfusion; 2018 Nov; 58(11):2469-2471. PubMed ID: 30284262
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoelectron microscopic detection of band 3 protein during erythroid cell differentiation by a monoclonal antibody.
    Sadahira Y; Hirao Y; Uehira K; Kimoto T
    Cell Struct Funct; 1991 Apr; 16(2):141-7. PubMed ID: 1860142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells.
    Heathcote D; Carroll T; Wang JJ; Flower R; Rodionov I; Tuzikov A; Bovin N; Henry S
    Transfusion; 2010 Mar; 50(3):635-41. PubMed ID: 19912581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice.
    Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM
    Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro production of red blood cells for future transfusion medicine].
    Kurita R
    Rinsho Ketsueki; 2023; 64(6):482-488. PubMed ID: 37407471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to recognize and resolve reagent-dependent reactivity: a review.
    Patch GC; Hutchinson CF; Lang NA; Khalife G
    Immunohematology; 2016 Sep; 32(3):96-99. PubMed ID: 27834481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells.
    Hiroyama T; Miharada K; Sudo K; Danjo I; Aoki N; Nakamura Y
    PLoS One; 2008 Feb; 3(2):e1544. PubMed ID: 18253492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of expression of the components of the Kell blood group complex.
    Pu JJ; Redman CM; Visser JW; Lee S
    Transfusion; 2005 Jun; 45(6):969-74. PubMed ID: 15934996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
    Thedsawad A; Taka O; Wanachiwanawin W
    Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of immortalized erythroid progenitor cell lines derived from a common cell source.
    Kurita R; Funato K; Abe T; Watanabe Y; Shiba M; Tadokoro K; Nakamura Y; Nagai T; Satake M
    Exp Hematol; 2019 Jan; 69():11-16. PubMed ID: 30326248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.